Journal of the National Cancer Institute, 0027-8874

Journal

1 - 28 out of 28Page size: 100

Publications

  1. 2021
  2. Published

    The effect of metformin vs placebo on sex hormones in Canadian cancer trials group MA.32

    Daniel Rea & 5 others, , Feb 2021, In: Journal of the National Cancer Institute. 113, 2, p. 192-198 7 p.

    Research output: Contribution to journal › Article › peer-review

  3. 2019
  4. Published

    Systematic evaluation of Patient-Reported Outcome protocol content and reporting in cancer trials

    Derek Kyte, Ameeta Retzer, Khaled Ahmed, Tom Keeley, Grace Turner & Melanie Calvert, Nov 2019, In: Journal of the National Cancer Institute. 111, 11, p. 1170-1178 9 p.

    Research output: Contribution to journal › Article › peer-review

  5. 2018
  6. Published

    Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial

    Daniel Rea, 1 Jun 2018, In: Journal of the National Cancer Institute. 110, 6, p. 616-627 12 p.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Risk of soft-tissue sarcoma among 69 460 five-year survivors of childhood cancer in Europe

    Michael Hawkins & 21 others, , Raoul Reulen, Jun 2018, In: Journal of the National Cancer Institute. 110, 6, p. 649–660

    Research output: Contribution to journal › Article › peer-review

  8. Published

    Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe

    Raoul Reulen & 20 others, & Michael Hawkins, Feb 2018, In: Journal of the National Cancer Institute. 110, 2

    Research output: Contribution to journal › Article › peer-review

  9. Published

    Relapse-free survival as a surrogate for overall survival in the evaluation of stage II-III melanoma adjuvant therapy

    Keith Wheatley, Natalie Rowland, 1 Jan 2018, In: Journal of the National Cancer Institute. 110, 1

    Research output: Contribution to journal › Article › peer-review

  10. 2017
  11. Published

    Pregnancy and labour complications in female survivors of childhood cancer: the British childhood cancer survivor study

    Raoul Reulen & Michael Hawkins, Nov 2017, In: Journal of the National Cancer Institute. 109, 11, djx056.

    Research output: Contribution to journal › Article › peer-review

  12. 2016
  13. Published

    Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others

    Burton Marshall, Peter Hall, Christopher Poole, Helena Earl, Daniel Rea, Christopher McCabe & 1 others, , Sep 2016, In: Journal of the National Cancer Institute. 108, 9

    Research output: Contribution to journal › Article › peer-review

  14. Published

    HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3,680 cases

    Davy Rapozo, Jun 2016, In: Journal of the National Cancer Institute. 108, 6

    Research output: Contribution to journal › Article › peer-review

  15. 2015
  16. Published

    Prognostic significance of POLE proofreading mutations in endometrial cancer

    Ian Tomlinson, 2015, In: Journal of the National Cancer Institute.

    Research output: Contribution to journal › Article › peer-review

  17. 2012
  18. Published

    Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis

    Anthony Kong, 7 Nov 2012, In: Journal of the National Cancer Institute. 104, 21, p. 1625-34 10 p.

    Research output: Contribution to journal › Article › peer-review

  19. 2010
  20. Published

    Educational Attainment Among Adult Survivors of Childhood Cancer in Great Britain: A Population-Based Cohort Study.

    Emma Lancashire, Raoul Reulen & Michael Hawkins, 27 Jan 2010, In: Journal of the National Cancer Institute. 102, 4, p. 254-270 17 p.

    Research output: Contribution to journal › Article

  21. 2009
  22. Published

    Re: Selenium and Vitamin E: Interesting Biology and Dashed Hope

    Maurice Zeegers, 7 Oct 2009, In: Journal of the National Cancer Institute. 101, 19, p. 1363-1364 2 p.

    Research output: Contribution to journal › Article

  23. Published

    Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial

    David Ferry, Gary Middleton, 2009, In: Journal of the National Cancer Institute. 101, 15, p. 1049-57 9 p.

    Research output: Contribution to journal › Article › peer-review

  24. 2008
  25. Published

    Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial

    Emilio Porfiri, 15 Oct 2008, In: Journal of the National Cancer Institute. 100, 20, p. 1454-63 10 p.

    Research output: Contribution to journal › Article

  26. Published

    Speeding up the evaluation of new agents in cancer

    Nicholas James, 1 Sep 2008, In: Journal of the National Cancer Institute. 100, 17, p. 1204-1214 11 p.

    Research output: Contribution to journal › Editorial

  27. Published

    Extent of smoking and age at initiation of smoking among adult survivors of childhood cancer in Britain

    Emma Lancashire, Raoul Reulen, Aliki Taylor & Michael Hawkins, 6 Aug 2008, In: Journal of the National Cancer Institute. 100, 15, p. 1068-81 14 p.

    Research output: Contribution to journal › Article

  28. 2007
  29. Published

    Oral sodium clodronate for non-metastatic prostate cancer - results of a randomized double-blind placebo-controlled trial: Medical Research Council PRO4 (ISRCTN61384873)

    Nicholas James, 16 May 2007, In: Journal of the National Cancer Institute. 99, 10, p. 765-776 12 p.

    Research output: Contribution to journal › Article

  30. 2006
  31. Published

    Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

    Jayne Wilson, Josie Sandercock, Christopher Hyde, 17 May 2006, In: Journal of the National Cancer Institute. 98, 10, p. 708-714 7 p.

    Research output: Contribution to journal › Article › peer-review

  32. Published

    PMS2 mutations in childhood cancer

    Eamonn Maher, 1 Jan 2006, In: Journal of the National Cancer Institute. 98, 5, p. 358-361 4 p.

    Research output: Contribution to journal › Article

  33. 2005
  34. Published

    A randomized Phase III study of doxorubicin versus cisplatin/interferon alpha-2b/Docorubicin/Fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma

    Philip Johnson, 19 Oct 2005, In: Journal of the National Cancer Institute. 97, p. 1532-1538 7 p.

    Research output: Contribution to journal › Article

  35. Published

    Cancer risks and mortality in heterozygous ATM mutation carriers

    James Last, Anne Reiman, Philip Byrd, Malcolm Taylor, 1 Jun 2005, In: Journal of the National Cancer Institute. 97, p. 813-822 10 p.

    Research output: Contribution to journal › Article

  36. Published

    Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins

    18 May 2005, In: Journal of the National Cancer Institute. 97, 10, p. 733-747 15 p.

    Research output: Contribution to journal › Article

  37. Published

    Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma

    & 2 others, & Philip Johnson, 6 Apr 2005, In: Journal of the National Cancer Institute. 97, p. 536-539 4 p.

    Research output: Contribution to journal › Article

  38. 2004
  39. Published

    Correspondence. Re: Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries

    Tom Sorahan, 1 Jan 2004, In: Journal of the National Cancer Institute. 96, p. 966-967 2 p.

    Research output: Contribution to journal › Article

  40. 2002
  41. Published

    Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma

    Philip Johnson, 6 Nov 2002, In: Journal of the National Cancer Institute. 94, p. 1614-1619 6 p.

    Research output: Contribution to journal › Article

  42. Published

    The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis

    Philip Johnson, 1 Sep 2002, In: Journal of the National Cancer Institute. 94, 18, p. 1381-1395 15 p.

    Research output: Contribution to journal › Article

  43. 2001
  44. Published

    Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression

    Farida Latif, 1 May 2001, In: Journal of the National Cancer Institute. 93, 9, p. 691-699 9 p.

    Research output: Contribution to journal › Article